• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HBeAg阳性状态下HBV突变株的组合与演变可预测HBeAg血清学转换后的临床结局。

Combination and evolution of HBV mutant strains in the HBeAg-positive status predict clinical outcomes after HBeAg seroconversion.

作者信息

Chen Chien-Hung, Lee Chuan-Mo, Wang Jing-Houng, Hu Tsung-Hui, Hung Chao-Hung, Changchien Chi-Sin, Lu Sheng-Nan

机构信息

Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, 123 Ta Pei Road, Kaohsiung, Taiwan.

School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.

出版信息

Hepatol Int. 2013 Jun;7(2):477-88. doi: 10.1007/s12072-012-9381-4. Epub 2012 Jun 21.

DOI:10.1007/s12072-012-9381-4
PMID:26201780
Abstract

PURPOSE

We investigated whether the combined presence and evolution of hepatitis B virus (HBV) mutant strains in the hepatitis B e antigen (HBeAg)-positive status can predict clinical outcomes after HBeAg seroconversion.

METHODS

One hundred and eighty-six patients with spontaneous HBeAg seroconversion were enrolled into this longitudinal study. The sequences of pre-S, core promoter, and precore regions were determined at study entry and at the visit immediately before HBeAg seroconversion.

RESULTS

Age ≥40 years at HBeAg seroconversion, male sex, and higher HBV DNA levels at entry were independent predictors for HBeAg-negative chronic hepatitis B (CHB). Patients with combined mutations of pre-S deletions and T1762/A1764 had a significantly increased risk of cirrhosis and hepatocellular carcinoma (HCC) compared to patients with the wild type at both genomic regions. Combinations of pre-S deletions and T1762/A1764 were found on the same HBV genome by cloning analysis of full-length HBV genomes. Patients with a persistent presence of pre-S deletions and T1762/A1764 mutations, and new development of pre-S deletions in the HBeAg-positive status were significantly at an increased risk of HBeAg-negative CHB, cirrhosis, and HCC after HBeAg seroconversion than those with a persistent presence of the wild type at both genomic regions. After adjusting the other risk factors, the evolution of pre-S deletions was an independent predictor for cirrhosis [hazard ratio (HR): 1.52, 95 % confidence interval (CI) 1.02-2.25] and HCC (HR: 4.0, 95 % CI 1.6-10.1).

CONCLUSIONS

The combined presence and evolution of pre-S deletions and T1762/A1764 in the HBeAg-positive status was a useful factor significantly predictive of clinical outcomes in patients with spontaneous HBeAg seroconversion.

摘要

目的

我们研究了乙肝e抗原(HBeAg)阳性状态下乙肝病毒(HBV)突变株的联合存在及演变是否能预测HBeAg血清学转换后的临床结局。

方法

186例自发HBeAg血清学转换的患者被纳入这项纵向研究。在研究入组时以及HBeAg血清学转换前的一次随访中测定前S区、核心启动子区和前核心区的序列。

结果

HBeAg血清学转换时年龄≥40岁、男性以及入组时较高的HBV DNA水平是HBeAg阴性慢性乙型肝炎(CHB)的独立预测因素。与两个基因组区域均为野生型的患者相比,前S区缺失和T1762/A1764联合突变的患者发生肝硬化和肝细胞癌(HCC)的风险显著增加。通过对全长HBV基因组进行克隆分析,在前S区缺失和T1762/A1764的联合突变存在于同一HBV基因组上。与两个基因组区域均持续存在野生型的患者相比,在HBeAg阳性状态下持续存在前S区缺失和T1762/A1764突变以及新出现前S区缺失的患者在HBeAg血清学转换后发生HBeAg阴性CHB、肝硬化和HCC的风险显著增加。在对其他危险因素进行校正后,前S区缺失的演变是肝硬化[风险比(HR):1.52,95%置信区间(CI)1.02 - 2.25]和HCC(HR:4.0,95%CI 1.6 - 10.1)的独立预测因素。

结论

HBeAg阳性状态下前S区缺失和T1762/A1764的联合存在及演变是自发HBeAg血清学转换患者临床结局的一个显著预测因素。

相似文献

1
Combination and evolution of HBV mutant strains in the HBeAg-positive status predict clinical outcomes after HBeAg seroconversion.HBeAg阳性状态下HBV突变株的组合与演变可预测HBeAg血清学转换后的临床结局。
Hepatol Int. 2013 Jun;7(2):477-88. doi: 10.1007/s12072-012-9381-4. Epub 2012 Jun 21.
2
Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.B型和C型乙肝病毒基因型HBeAg阳性患者核心启动子和前核心突变的临床意义及演变:一项纵向研究
Liver Int. 2007 Aug;27(6):806-15. doi: 10.1111/j.1478-3231.2007.01505.x.
3
Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.HBeAg阴性患者中与晚期肝病相关的乙肝病毒前S区缺失及复杂突变
Gastroenterology. 2007 Nov;133(5):1466-74. doi: 10.1053/j.gastro.2007.09.002. Epub 2007 Sep 6.
4
Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.未治疗的年长基因型 C 中国患者中乙型肝炎病毒基本核心和前核心/核心启动子突变对肝细胞癌的作用。
J Viral Hepat. 2011 Oct;18(10):e423-31. doi: 10.1111/j.1365-2893.2011.01458.x. Epub 2011 Apr 4.
5
Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan.台湾地区乙型肝炎病毒(HBV)基因型以及影响HBV e抗原表达的前核心和核心启动子突变的临床意义
J Clin Microbiol. 2005 Dec;43(12):6000-6. doi: 10.1128/JCM.43.12.6000-6006.2005.
6
Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.韩国肝细胞癌患者中乙型肝炎病毒C2亚基因型增强子II/核心启动子/前核心区域的特定突变
J Med Virol. 2009 Jun;81(6):1002-8. doi: 10.1002/jmv.21501.
7
Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion.乙肝e抗原血清学转换的乙肝携带者前核心/核心启动子突变的演变
J Med Virol. 2004 Oct;74(2):237-45. doi: 10.1002/jmv.20176.
8
[The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].[韩国慢性乙型肝炎病毒感染患者前核心区和核心启动子突变的患病率及临床意义]
Taehan Kan Hakhoe Chi. 2002 Jun;8(2):149-56.
9
A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.一项关于乙型肝炎病毒核心启动子区域双突变对C基因型慢性活动性肝炎患者HBeAg血清学转换及疾病进展影响的13年纵向研究。
J Viral Hepat. 2007 Mar;14(3):169-75. doi: 10.1111/j.1365-2893.2006.00788.x.
10
[Study on the distribution of hepatitis B virus precore and basic core promoter mutations in Guizhou area].[贵州地区乙型肝炎病毒前核心区及基本核心启动子变异分布研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2007 Feb;28(2):169-72.

引用本文的文献

1
Recent Advances in HBV Reactivation Research.HBV 再激活研究的最新进展。
Biomed Res Int. 2018 Dec 26;2018:2931402. doi: 10.1155/2018/2931402. eCollection 2018.
2
Patients with interferon-induced HBeAg seroconversion have a higher risk of HBV reactivation and HBeAg seroreversion.干扰素诱导的HBeAg血清学转换患者发生HBV再激活和HBeAg血清学逆转的风险更高。
Hepatol Int. 2014 Jul;8(3):365-74. doi: 10.1007/s12072-014-9542-8. Epub 2014 May 31.
3
High risk of hepatitis B virus reactivation in nucleos(t)ide analogue-induced hepatitis B e antigen seroconverters older than 40 years.

本文引用的文献

1
Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.血清乙型肝炎表面抗原水平可预测乙型肝炎 e 抗原血清学转换者的表面抗原丢失。
Gastroenterology. 2011 Aug;141(2):517-25, 525.e1-2. doi: 10.1053/j.gastro.2011.04.046. Epub 2011 Apr 28.
2
Evolution of hepatitis B genotype C viral quasi-species during hepatitis B e antigen seroconversion.乙型肝炎 C 基因型病毒准种在乙型肝炎 e 抗原血清转换期间的演变。
J Hepatol. 2011 Jan;54(1):19-25. doi: 10.1016/j.jhep.2010.06.018. Epub 2010 Aug 25.
3
Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B.
核苷(酸)类似物诱导的 HBeAg 血清学转换大于 40 岁的患者乙型肝炎病毒再激活的风险较高。
Dig Dis Sci. 2014 Oct;59(10):2580-7. doi: 10.1007/s10620-014-3194-3. Epub 2014 May 21.
慢性乙型肝炎患者自发出现乙型肝炎 e 抗原血清学转换后的年龄特异性预后。
Hepatology. 2010 Feb;51(2):435-44. doi: 10.1002/hep.23348.
4
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update.亚太地区慢性乙型肝炎管理共识声明:2008 年更新版。
Hepatol Int. 2008 Sep;2(3):263-83. doi: 10.1007/s12072-008-9080-3. Epub 2008 May 10.
5
Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.无症状慢性乙型肝炎病毒感染患者丙氨酸转氨酶水平的自发升高。
Gastroenterology. 2009 Apr;136(4):1272-80. doi: 10.1053/j.gastro.2009.01.011. Epub 2009 Jan 16.
6
Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study.乙型肝炎病毒前S/表面及核心启动子/前核心区域联合突变增加肝细胞癌风险:一项病例对照研究
J Infect Dis. 2008 Dec 1;198(11):1634-42. doi: 10.1086/592990.
7
Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B.慢性乙型肝炎患者乙肝e抗原血清学转换后乙肝再激活的预测因素
Gastroenterology. 2007 Nov;133(5):1458-65. doi: 10.1053/j.gastro.2007.08.039. Epub 2007 Aug 21.
8
Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.HBeAg阴性患者中与晚期肝病相关的乙肝病毒前S区缺失及复杂突变
Gastroenterology. 2007 Nov;133(5):1466-74. doi: 10.1053/j.gastro.2007.09.002. Epub 2007 Sep 6.
9
Viral quasi-species evolution during hepatitis Be antigen seroconversion.乙肝e抗原血清学转换期间的病毒准种进化
Gastroenterology. 2007 Sep;133(3):951-8. doi: 10.1053/j.gastro.2007.06.011. Epub 2007 Jun 20.
10
Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.B型和C型乙肝病毒基因型HBeAg阳性患者核心启动子和前核心突变的临床意义及演变:一项纵向研究
Liver Int. 2007 Aug;27(6):806-15. doi: 10.1111/j.1478-3231.2007.01505.x.